PMEF
RCEL icon

Point72 Middle East FZE’s Avita Medical RCEL Stock Holding History

Point72 Middle East FZE’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-803
Closed -$11K – 1043
2023
Q4 		$11K Buy
+803
New +$9.21K ﹤0.01% 1395
2023
Q2 		– Sell
-4,609
Closed -$64.4K – 1987
2023
Q1 		$64.4K Buy
+4,609
New +$49K ﹤0.01% 1219

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Point72 Middle East FZE's RCEL Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Avita Medical (RCEL) in Q1 2024, closing a stake of 803 shares — an estimated $11K sold.

Point72 Middle East FZE first reported a position in RCEL in Q1 2023 and held it in 2 quarters. The position peaked at $64.4K in Q1 2023. 82 funds tracked by Wall St. Rank hold RCEL as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Avita Medical position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 803 Avita Medical shares in Q1 2024, an estimated $11K.
  • Point72 Middle East FZE first reported a position in Avita Medical in Q1 2023 and held it in 2 quarters.
  • Point72 Middle East FZE's Avita Medical position peaked at $64.4K in Q1 2023.
  • 82 funds tracked by Wall St. Rank held Avita Medical as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.